Total Payments
$259,140
2024 Payments
$26,845
Companies
16
Transactions
228
Medicare Patients
897
Medicare Billing
$192,924
Payment Breakdown by Category
Other$193,260 (74.6%)
Travel$31,271 (12.1%)
Consulting$30,083 (11.6%)
Food & Beverage$4,526 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $186,210 | 52 | 71.9% |
| Travel and Lodging | $31,271 | 80 | 12.1% |
| Consulting Fee | $30,083 | 22 | 11.6% |
| Honoraria | $7,050 | 4 | 2.7% |
| Food and Beverage | $4,526 | 70 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Kite Pharma, Inc. | $138,885 | 119 | $0 (2023) |
| BeiGene USA, Inc. | $43,267 | 32 | $0 (2024) |
| ADC Therapeutics America, Inc. | $34,602 | 23 | $0 (2024) |
| Genentech USA, Inc. | $8,428 | 14 | $0 (2024) |
| Celgene Corporation | $7,330 | 7 | $0 (2019) |
| Epizyme, Inc., | $4,649 | 5 | $0 (2022) |
| Incyte Corporation | $4,018 | 3 | $0 (2022) |
| Spectrum Pharmaceuticals Inc. | $3,684 | 7 | $0 (2017) |
| Verastem, Inc. | $3,458 | 2 | $0 (2019) |
| Pharmacyclics LLC, An AbbVie Company | $3,199 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26,845 | 25 | BeiGene USA, Inc. ($16,613) |
| 2023 | $37,818 | 29 | BeiGene USA, Inc. ($26,654) |
| 2022 | $68,519 | 54 | Kite Pharma, Inc. ($47,116) |
| 2021 | $29,249 | 17 | Kite Pharma, Inc. ($11,220) |
| 2020 | $23,123 | 23 | Kite Pharma, Inc. ($20,373) |
| 2019 | $62,580 | 59 | Kite Pharma, Inc. ($46,177) |
| 2018 | $7,251 | 13 | Kite Pharma, Inc. ($6,005) |
| 2017 | $3,754 | 8 | Spectrum Pharmaceuticals Inc. ($3,684) |
All Payment Transactions
228 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Genentech USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $312.50 | General |
| 09/24/2024 | ADC Therapeutics America, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,960.00 | General |
| 09/20/2024 | ADC Therapeutics America, Inc. | — | Travel and Lodging | Cash or cash equivalent | $143.54 | General |
| 09/18/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $119.21 | General |
| 09/14/2024 | ADC Therapeutics America, Inc. | — | Travel and Lodging | Cash or cash equivalent | $559.95 | General |
| 07/11/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: Oncology | ||||||
| 07/11/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Travel and Lodging | In-kind items and services | $852.86 | General |
| Category: Oncology | ||||||
| 07/11/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $122.91 | General |
| Category: Oncology | ||||||
| 06/25/2024 | ADC Therapeutics America, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,100.00 | General |
| 06/20/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $104.13 | General |
| 05/15/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: Oncology | ||||||
| 05/15/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Travel and Lodging | In-kind items and services | $1,043.36 | General |
| Category: Oncology | ||||||
| 05/15/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $133.35 | General |
| Category: Oncology | ||||||
| 04/05/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $143.25 | General |
| Category: Oncology | ||||||
| 03/08/2024 | Genentech USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $312.50 | General |
| 02/14/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,200.00 | General |
| Category: Oncology | ||||||
| 02/14/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Travel and Lodging | Cash or cash equivalent | $60.00 | General |
| Category: Oncology | ||||||
| 02/14/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | Cash or cash equivalent | $29.27 | General |
| Category: Oncology | ||||||
| 02/06/2024 | ADC Therapeutics America, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $620.00 | General |
| 01/27/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Travel and Lodging | In-kind items and services | $746.20 | General |
| Category: Oncology | ||||||
| 01/27/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Travel and Lodging | In-kind items and services | $315.27 | General |
| Category: Oncology | ||||||
| 01/27/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $49.98 | General |
| Category: Oncology | ||||||
| 01/27/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $49.98 | General |
| Category: Oncology | ||||||
| 01/27/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $33.41 | General |
| Category: Oncology | ||||||
| 01/27/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $33.41 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 227 | 536 | $202,954 | $51,886 |
| 2022 | 5 | 225 | 567 | $267,718 | $53,678 |
| 2021 | 5 | 225 | 440 | $217,146 | $44,810 |
| 2020 | 5 | 220 | 512 | $242,848 | $42,550 |
Total Patients
897
Total Services
2,055
Medicare Billing
$192,924
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 127 | 243 | $106,560 | $24,202 | 22.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 43 | 233 | $67,350 | $20,939 | 31.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $13,818 | $3,318 | 24.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 19 | $10,194 | $2,211 | 21.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 15 | 16 | $5,032 | $1,215 | 24.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 120 | 278 | $150,676 | $27,904 | 18.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 45 | 223 | $78,050 | $17,900 | 22.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 21 | $14,238 | $3,118 | 21.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 23 | 23 | $15,778 | $2,997 | 19.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 20 | 22 | $8,976 | $1,758 | 19.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 96 | 181 | $98,102 | $20,279 | 20.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 27 | 122 | $42,700 | $10,656 | 25.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 54 | 89 | $48,238 | $7,640 | 15.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 19 | 19 | $13,034 | $2,749 | 21.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 12 | $8,136 | $2,023 | 24.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 17 | 17 | $6,936 | $1,463 | 21.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 95 | 232 | $125,744 | $17,798 | 14.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 47 | 196 | $68,600 | $15,023 | 21.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 24 | 28 | $18,984 | $4,137 | 21.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 24 | 24 | $16,464 | $3,003 | 18.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 30 | 32 | $13,056 | $2,589 | 19.8% |
About Dr. Matthew Mckinney, M.D
Dr. Matthew Mckinney, M.D is a Hematology & Oncology healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1982899837.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Mckinney, M.D has received a total of $259,140 in payments from pharmaceutical and medical device companies, with $26,845 received in 2024. These payments were reported across 228 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($186,210).
As a Medicare-enrolled provider, Mckinney has provided services to 897 Medicare beneficiaries, totaling 2,055 services with total Medicare billing of $192,924. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Durham, NC
- Active Since 09/12/2007
- Last Updated 06/25/2013
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1982899837
Products in Payments
- Yescarta (Drug) $128,898
- BRUKINSA (Drug) $42,292
- Revlimid (Drug) $7,330
- TAZVERIK (Drug) $3,939
- Folotyn (Drug) $3,684
- Copiktra (Drug) $3,458
- Imbruvica (Drug) $3,199
- MONJUVI (Drug) $2,320
- Rituxan (Biological) $2,315
- UKONIQ (Drug) $2,025
- ADCETRIS (Biological) $1,446
- GAZYVA (Biological) $192.12
- Lunsumio (Biological) $70.74
- KYMRIAH (Biological) $62.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Durham
Michael Morse, M.d, M.D
Hematology & Oncology — Payments: $2.8M
Hematology & Oncology $2.8M
Cristina Gasparetto, M.d, M.D
Hematology & Oncology — Payments: $765,745
Hematology & Oncology $765,745
Phillip Febbo, M.d, M.D
Hematology & Oncology — Payments: $751,716
Hematology & Oncology $751,716
Ivy Altomare, Md, MD
Hematology & Oncology — Payments: $369,810
Hematology & Oncology $369,810
Jeffrey Crawford, M.d, M.D
Hematology & Oncology — Payments: $273,264
Hematology & Oncology $273,264
Dr. Kimberly Blackwell, Md, MD
Hematology & Oncology — Payments: $209,836
Hematology & Oncology $209,836